Search NLS News

Svar Life Science has announced the expansion of the company’s biologics testing capacity with a GMP certification. Svar’s QC laboratories have been inspected by an independent auditor (Swedish Medical Products Agency) and approved to begin QC analysis in line with the applicable GMP regulations for potency testing of biologics. Svar Life Science AB has been […]

To keep up with the development of new pharmaceuticals and medical devices, more clinical studies need to be conducted – which is a challenge in the healthcare setting due to limited time and resources. Contract research organizations (CROs) are vital in bringing together industry, healthcare, and regulatory agencies to design and conduct clinical studies. By […]

Connect in Pharma is promoting a new era of cross-sector collaboration within the pharmaceutical industry. The newly announced agenda for Connect in Pharma sends a strong message for more cross-sector collaboration. Technology gurus, consultancy experts and motivational speakers from a wide range of industries are calling for a new, modern era of pharmaceutical packaging and […]

The investors include several life science investors such as Life Science Invest Gamma, but also existing and new private investors. The raised capital will mainly be used for final product development and for preparing an FDA 510k application for the company’s anesthesia catheter Solutio. Solutio minimizes the pain of implementing the golden standard methods for […]

Herantis Pharma has announced the dosing of the first healthy volunteer in the Phase 1a clinical study for HER-096. The Phase 1a clinical study will assess safety, tolerability, and blood-brain barrier penetration of subcutaneously administered HER-096. “We are excited to start the Phase 1a clinical study with HER-096. This is an important milestone on our […]

Nykode Therapeutics has announced results from the VB-C-02 trial, investigating the use of Nykode’s therapeutic cancer vaccine candidate VB10.16 in combination with Roche’s cancer immunotherapy Tecentriq in patients with advanced or recurrent, non-resectable HPV16-positive cervical cancer. “We are extremely encouraged by the unprecedented data that indicates a doubling of the survival of PD-L1+ patients with […]

Evaxion Biotech has announced preclinical data demonstrating the effectiveness of its AI-driven viral vaccine discovery platform. The presented preclinical study was conducted in collaboration with associate professor Girish Kirimanjeswara, Pennsylvania State University, US. Our RAVEN platform represents a paradigm shift in vaccine development, identifying vaccine candidates against any existing, newly emerging, and mutating viral diseases […]

The issued patent covers the Dosage Manager device platform developed by OnDosis for dosing of oral solid medicines in the form of pellets. The issued patent is the first relating to OnDosis device and its core design and functionality, and the company expects further patents to follow in due course from the company’s extensive patent […]

Affibody have shared long-term 46-week data from a global Phase 2 trial of izokibep in psoriatic arthritis (PsA). The randomized double-blind, placebo-controlled, Phase 2 clinical trial evaluated the safety and efficacy of izokibep dosed 80 mg every two weeks (Q2W) or 40 mg Q2W, versus placebo Q2W, in adult patients with active PsA. The global […]

The United States Patent and Trademark Office (USPTO) has granted the company’s patent application directed to gluconic acid derivatives for preventing and/or treating bacterial infections. “The US patent covering treatment and prevention of vaginal bacterial infections by GDL, or pHyph, strengthens Gedea’s position in one of the largest markets for treatment of these conditions. pHyph […]